All entries for: Candel Therapeutics, Inc.

May 14, 2026

Candel Therapeutics, Inc.

Neutral Outlook

Needham, Massachusetts
51-200 employees

While we do not believe that the IRA or its effects will impact our ability to obtain patents in the near future, we cannot be certain that it will not affect our patent strategy in the long run.

Disease Area: Immune Diseases, Oncology
Drug Type: Biologic
March 12, 2026

Candel Therapeutics, Inc.

Neutral Outlook

Needham, Massachusetts
51-200 employees

The effects of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Oncology
Drug Type: Biologic
August 14, 2025

Candel Therapeutics, Inc.

Neutral Outlook

Needham, Massachusetts
51-200 employees

The Inflation Reduction Act that creates a distinction between small molecule and large molecule products for purposes of determining when a drug may be eligible for drug price negotiation.

Disease Area: Oncology
Drug Type: Biologic, Small Molecule
Scroll to Top